A gammaherpesvirus-secreted activator of Vβ4+ CD8 + T cells regulates chronic infection and immunopathology

Journal of Experimental Medicine

Volumn 205, Issue 3, 2008, Pages 669-684

  Evans, Andrew G ^a   Moser, Janice M ^a,b   Krug, Laurie T ^a   Pozharskaya, Veranika ^a   Mora, Ana L ^a   Speck, Samuel H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VaxDesign Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; PROTEIN M1; SUPERANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EFFECTOR CELL; EXHAUSTION; FIBROSIS; HERPES VIRUS; HERPES VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFLAMMATION; MOUSE; MURINE GAMMAHERPERVIRUS 68; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS CELL INTERACTION; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; GAMMAHERPESVIRINAE; HERPESVIRIDAE INFECTIONS; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, INTERFERON; VIRAL PROTEINS;

EID: 41149141391     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20071135     Document Type: Article

References (78)

1. Knipe, D.M., P.M. Howley, D.E. Griffin, R.A. Lamb, S.E. Straus, M.A. Martin, and B. Roizman, editors. 2007. Fields Virology. Lippincott Williams and Wilkins, Philadelphia.
2. Virgin, H.W., P. Latreille, P. Wamsley, K. Hallsworth, K.E. Weck, A.J. Dal Canto, and S.H. Speck. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:5894-5904.
3. McGeoch, D.J., D. Gatherer, and A. Dolan. 2005. On phylogenetic relationships among major lineages of the Gammaherpesvirinae. J. Gen. Virol. 86:307-316.
4. Speck, S.H., and H.W. Virgin. 1999. Host and viral genetics of chronic infection: a mouse model of gamma-herpesvirus pathogenesis. Curr. Opin. Microbiol. 2:403-409.
5. Virgin, H.W., and S.H. Speck. 1999. Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection. Curr. Opin. Immunol. 11:371-379.
6. Dutia, B.M., C.J. Clarke, D.J. Allen, and A.A. Nash. 1997. Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells. J. Virol. 71:4278-4283.
7. Steed, A.L., E.S. Barton, S.A. Tibbetts, D.L. Popkin, M.L. Lutzke, R. Rochford, and H.W. Virgin. 2006. Gamma interferon blocks gamma-herpesvirus reactivation from latency. J. Virol. 80:192-200.
8. Steed, A., T. Buch, A. Waisman, and H.W. Virgin. 2007. Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner. J. Virol. 81:6134-6140.
9. Ebrahimi, B., B.M. Dutia, D.G. Brownstein, and A.A. Nash. 2001. Murine gammaherpesvirus-68 infection causes multi-organ fibrosis and alters leukocyte trafficking in interferon-gamma receptor knockout mice. Am. J. Pathol. 158:2117-2125.
10. Mora, A.L., E. Torres-Gonzalez, M. Rojas, C. Corredor, J. Ritzenthaler, J. Xu, J. Roman, K. Brigham, and A. Stecenko. 2006. Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. Am. J. Respir. Cell Mol. Biol. 35:466-473.
11. Mora, A.L., E. Torres-Gonzalez, M. Rojas, J. Xu, J. Ritzenthaler, S.H. Speck, J. Roman, K. Brigham, and A. Stecenko. 2007. Control of virus reactivation arrests pulmonary herpesvirus induced fibrosis in IFN{gamma} R deficient mice. Am. J. Respir. Crit. Care Med. 175:1139-1150.
12. Mora, A.L., C.R. Woods, A. Garcia, J. Xu, M. Rojas, S.H. Speck, J. Roman, K.L. Brigham, and A.A. Stecenko. 2005. Lung infection with gamma-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 289:L711-L721.
13. Weck, K.E., A.J. Dal Canto, J.D. Gould, A.K. O'Guin, K.A. Roth, J.E. Saffitz, S.H. Speck, and H.W. Virgin. 1997. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nat. Med. 3:1346-1353.
14. Dal Canto, A.J., P.E. Swanson, A.K. O'Guin, S.H. Speck, and H.W. Virgin. 2001. IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site. J. Clin. Invest. 107:R15-R22.
15. Dal Canto, A.J., H.W. Virgin, and S.H. Speck. 2000. Ongoing viral replication is required for gammaherpesvirus 68-induced vascular damage. J. Virol. 74:11304-11310.
16. Clambey, E.T., H.W. Virgin, and S.H. Speck. 2000. Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J. Virol. 74:1973-1984.
17. Clambey, E.T., H.W. Virgin, and S.H. Speck. 2002. Characterization of a spontaneous 9.5-kilobase-deletion mutant of murine gammaherpes-virus 68 reveals tissue-specific genetic requirements for latency. J. Virol. 76:6532-6544.
18. Evans, A.G., N.J. Moorman, D.O. Willer, and S.H. Speck. 2006. The M4 gene of gammaHV68 encodes a secreted glycoprotein and is required for the efficient establishment of splenic latency. Virology. 344:520-531.
19. Herskowitz, J., M.A. Jacoby, and S.H. Speck. 2005. The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells. J. Virol. 79:2261-2273.
20. Jacoby, M.A., H.W. Virgin, and S.H. Speck. 2002. Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation. J. Virol. 76:1790-1801.
21. Macrae, A.I., E.J. Usherwood, S.M. Husain, E. Flano, I.J. Kim, D.L. Woodland, A.A. Nash, M.A. Blackman, J.T. Sample, and J.P. Stewart. 2003. Murid herpesvirus 4 strain 68 M2 protein is a B-cell-associated antigen important for latency but not lymphocytosis. J. Virol. 77: 9700-9709.
22. van Berkel, V., B. Levine, S.B. Kapadia, J.E. Goldman, S.H. Speck, and H.W. Virgin. 2002. Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis. J. Clin. Invest. 109:905-914.
23. Townsley, A.C., B.M. Dutia, and A.A. Nash. 2004. The m4 gene of murine gammaherpesvirus modulates productive and latent infection in vivo. J. Virol. 78:758-767.
24. Cardin, R.D., J.W. Brooks, S.R. Sarawar, and P.C. Doherty. 1996. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J. Exp. Med. 184:863-871.
25. Ehtisham, S., N.P. Sunil-Chandra, and A.A. Nash. 1993. Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J. Virol. 67:5247-5252.
26. Husain, S.M., E.J. Usherwood, H. Dyson, C. Coleclough, M.A. Coppola, D.L. Woodland, M.A. Blackman, J.P. Stewart, and J.T. Sample. 1999. Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes. Proc. Natl. Acad. Sci. USA. 96:7508-7513.
27. Liu, L., E.J. Usherwood, M.A. Blackman, and D.L. Woodland. 1999. T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice. J. Virol. 73:9849-9857.
28. Usherwood, E.J., D.J. Roy, K. Ward, S.L. Surman, B.M. Dutia, M.A. Blackman, J.P. Stewart, and D.L. Woodland. 2000. Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells. J. Exp. Med. 192:943-952.
29. Obar, J.J., S.G. Crist, D.C. Gondek, and E.J. Usherwood. 2004. Different functional capacities of latent and lytic antigen-specific CD8 T cells in murine gammaherpesvirus infection. J. Immunol. 172:1213-1219.
30. Obar, J.J., S. Fuse, E.K. Leung, S.C. Bellfy, and E.J. Usherwood. 2006. Gammaherpesvirus persistence alters key CD8 T-cell memory characteristics and enhances antiviral protection. J. Virol. 80:8303-8315.
31. Stevenson, P.G., G.T. Belz, J.D. Altman, and P.C. Doherty. 1999. Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection. Eur. J. Immunol. 29:1059-1067.
32. Tripp, R.A., A.M. Hamilton-Easton, R.D. Cardin, P. Nguyen, F.G. Behm, D.L. Woodland, P.C. Doherty, and M.A. Blackman. 1997. Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen? J. Exp. Med. 185:1641-1650.
33. Flano, E., C.L. Hardy, I.J. Kim, C. Frankling, M.A. Coppola, P. Nguyen, D.L. Woodland, and M.A. Blackman. 2004. T cell reactivity during infectious mononucleosis and persistent gammaherpesvirus infection in mice. J. Immunol. 172:3078-3085.
34. Doherty, P.C., R.A. Tripp, A.M. Hamilton-Easton, R.D. Cardin, D.L. Woodland, and M.A. Blackman. 1997. Tuning into immunological dissonance: an experimental model for infectious mononucleosis. Curr. Opin. Immunol. 9:477-483.
35. Blackman, M.A., E. Flano, E. Usherwood, and D.L. Woodland. 2000. Murine gamma-herpesvirus-68: a mouse model for infectious mononucleosis? Mol. Med. Today. 6:488-490.
36. Brooks, J.W., A.M. Hamilton-Easton, J.P. Christensen, R.D. Cardin, C.L. Hardy, and P.C. Doherty. 1999. Requirement for CD40 ligand, CD4(+) T cells, and B cells in an infectious mononucleosis-like syndrome. J. Virol. 73:9650-9654.
37. Coppola, M.A., E. Flano, P. Nguyen, C.L. Hardy, R.D. Cardin, N. Shastri, D.L. Woodland, and M.A. Blackman. 1999. Apparent MHC-independent stimulation of CD8+ T cells in vivo during latent murine gammaherpesvirus infection. J. Immunol. 163:1481-1489.
38. May, J.S., H.M. Coleman, B. Smillie, S. Efstathiou, and P.G. Stevenson. 2004. Forced lytic replication impairs host colonization by a latencydefi cient mutant of murine gammaherpesvirus-68. J. Gen. Virol. 85: 137-146.
39. Hardy, C.L., E. Flano, R.D. Cardin, I.J. Kim, P. Nguyen, S. King, D.L. Woodland, and M.A. Blackman. 2001. Factors controlling levels of CD8+ T-cell lymphocytosis associated with murine gamma-herpesvirus infection. Viral Immunol. 14:391-402.
40. Hardy, C.L., S.L. Silins, D.L. Woodland, and M.A. Blackman. 2000. Murine gamma-herpesvirus infection causes V(beta)4-specific CDR3-restricted clonal expansions within CD8(+) peripheral blood T lymphocytes. Int. Immunol. 12:1193-1204.
41. Braaten, D.C., J.S. McClellan, I. Messaoudi, S.A. Tibbetts, K.B. McClellan, J. Nikolich-Zugich, and H.W. Virgin. 2006. Effective control of chronic gamma-herpesvirus infection by unconventional MHC class Ia-independent CD8 T cells. PLoS Pathog. 2:e37.
42. Bowden, R.J., J.P. Simas, A.J. Davis, and S. Efstathiou. 1997. Murine gammaherpesvirus 68 encodes tRNA-like sequences which are expressed during latency. J. Gen. Virol. 78( Pt 7 ):1675-1687.
43. Simas, J.P., R.J. Bowden, V. Paige, and S. Efstathiou. 1998. Four tRNA-like sequences and a serpin homologue encoded by murine gammaherpesvirus 68 are dispensable for lytic replication in vitro and latency in vivo. J. Gen. Virol. 79( Pt 1 ):149-153.
44. Pfeffer, S., A. Sewer, M. Lagos-Quintana, R. Sheridan, C. Sander, F.A. Grasser, L.F. van Dyk, C.K. Ho, S. Shuman, M. Chien, et al. 2005. Identification of microRNAs of the herpesvirus family. Nat. Methods. 2:269-276.
45. Kaech, S.M., J.T. Tan, E.J. Wherry, B.T. Konieczny, C.D. Surh, and R. Ahmed. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4:1191-1198.
46. Moser, J.M., J. Gibbs, P.E. Jensen, and A.E. Lukacher. 2002. CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses. Nat. Immunol. 3:189-195.
47. Barber, D.L., E.J. Wherry, D. Masopust, B. Zhu, J.P. Allison, A.H. Sharpe, G.J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 439:682-687.
48. van Berkel, V., K. Preiter, H.W. Virgin, and S.H. Speck. 1999. Identification and initial characterization of the murine gammaherpesvirus 68 gene M3, encoding an abundantly secreted protein. J. Virol. 73:4524-4529.
49. Lafon, M., M. Lafage, A. Martinez-Arends, R. Ramirez, F. Vuillier, D. Charron, V. Lotteau, and D. Scott-Algara. 1992. Evidence for a viral superantigen in humans. Nature. 358:507-510.
50. Dobrescu, D., B. Ursea, M. Pope, A.S. Asch, and D.N. Posnett. 1995. Enhanced HIV-1 replication in V beta 12 T cells due to human cytomegalovirus in monocytes: evidence for a putative herpesvirus superantigen. Cell. 82:753-763.
51. Choi, Y., J.W. Kappler, and P. Marrack. 1991. A superantigen encoded in the open reading frame of the 3′ - long terminal repeat of mouse mammary tumour virus. Nature. 350:203-207.
52. Marrack, P., E. Kushnir, and J. Kappler. 1991. A maternally inherited superantigen encoded by a mammary tumour virus. Nature. 349:524-526.
53. Sutkowski, N., T. Palkama, C. Ciurli, R.P. Sekaly, D.A. Thorley-Lawson, and B.T. Huber. 1996. An Epstein-Barr virus-associated superantigen. J. Exp. Med. 184:971-980.
54. Yao, Z., E. Maraskovsky, M.K. Spriggs, J.I. Cohen, R.J. Armitage, and M.R. Alderson. 1996. Herpesvirus saimiri open reading frame 14, a protein encoded by T lymphotropic herpesvirus, binds to MHC class II molecules and stimulates T cell proliferation. J. Immunol. 156:3260-3266.
55. Moza, B., A.K. Varma, R.A. Buonpane, P. Zhu, C.A. Herfst, M.J. Nicholson, A.K. Wilbuer, N.P. Seth, K.W. Wucherpfennig, J.K. McCormick, et al. 2007. Structural basis of T-cell specificity and activation by the bacterial superantigen TSST-1. EMBO J. 26:1187-1197.
56. Mottershead, D.G., P.N. Hsu, R.G. Urban, J.L. Strominger, and B.T. Huber. 1995. Direct binding of the Mtv7 superantigen (Mls-1) to soluble MHC class II molecules. Immunity. 2:149-154.
57. Bueno, C., C.D. Lemke, G. Criado, M.L. Baroja, S.S. Ferguson, A.K. Rahman, C.D. Tsoukas, J.K. McCormick, and J. Madrenas. 2006. Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a Galpha11-dependent, PLC-beta-mediated pathway. Immunity. 25:67-78.
58. Flano, E., D.L. Woodland, and M.A. Blackman. 1999. Requirement for CD4+ T cells in V beta 4+CD8+ T cell activation associated with latent murine gammaherpesvirus infection. J. Immunol. 163:3403-3408.
59. Tibbetts, S.A., L.F. van Dyk, S.H. Speck, and H.W. Virgin. 2002. Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus. J. Virol. 76:7125-7132.
60. Sparks-Thissen, R.L., D.C. Braaten, K. Hildner, T.L. Murphy, K.M. Murphy, and H.W.t. Virgin. 2005. CD4 T cell control of acute and latent murine gammaherpesvirus infection requires IFNgamma. Virology. 338:201-208.
61. Sparks-Thissen, R.L., D.C. Braaten, S. Kreher, S.H. Speck, and H.W. Virgin. 2004. An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection. J. Virol. 78:6827-6835.
62. Usherwood, E.J., S.K. Meadows, S.G. Crist, S.C. Bellfy, and C.L. Sentman. 2005. Control of murine gammaherpesvirus infection is independent of NK cells. Eur. J. Immunol. 35:2956-2961.
63. Sharpe, A.H., E.J. Wherry, R. Ahmed, and G.J. Freeman. 2007. The function of programmed cell death 1 and its ligands in regulating auto-immunity and infection. Nat. Immunol. 8:239-245.
64. McClellan, K.B., S. Gangappa, S.H. Speck, and H.W. Virgin. 2006. Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses. PLoS Pathog. 2:e58.
65. Marques, S., S. Efstathiou, K.G. Smith, M. Haury, and J.P. Simas. 2003. Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes. J. Virol. 77:7308-7318.
66. Rickinson, A.B., and E. Kieff. 2007. Epstein-Barr virus. In Fields Virology. D.M. Knipe and P.M. Howley, editors. Lippincott Williams and Wilkins, Philadelphia. pp. 2655-2700.
67. Weck, K.E., S.S. Kim, H.I. Virgin, and S.H. Speck. 1999. B cells regulate murine gammaherpesvirus 68 latency. J. Virol. 73:4651-4661.
68. Tarakanova, V.L., F. Kreisel, D.W. White, and H.W. Virgin. 2007. Murine gammaherpesvirus 68 genes both induce and suppress lymphoproliferative disease. J. Virol. 82:1034-1039.
69. Sutkowski, N., B. Conrad, D.A. Thorley-Lawson, and B.T. Huber. 2001. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity. 15:579-589.
70. Sutkowski, N., G. Chen, G. Calderon, and B.T. Huber. 2004. Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen. J. Virol. 78:7852-7860.
71. Tai, A.K., M. Lin, F. Chang, G. Chen, F. Hsiao, N. Sutkowski, and B.T. Huber. 2006. Murine Vbeta3+ and Vbeta7+ T cell subsets are specific targets for the HERV-K18 Env superantigen. J. Immunol. 177:3178-3184.
72. Ma, C.S., K.E. Nichols, and S.G. Tangye. 2007. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. Annu. Rev. Immunol. 25:337-379.
73. Crotty, S., M.M. McCausland, R.D. Aubert, E.J. Wherry, and R. Ahmed. 2006. Hypogammaglobulinemia and exacerbated CD8 T-cell-mediated immunopathology in SAP-deficient mice with chronic LCMV infection mimics human XLP disease. Blood. 108:3085-3093.
74. Chen, G., A.K. Tai, M. Lin, F. Chang, C. Terhorst, and B.T. Huber. 2005. Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice. J. Immunol. 175:2212-2218.
75. Yin, L., U. Al-Alem, J. Liang, W.M. Tong, C. Li, M. Badiali, J.J. Medard, J. Sumegi, Z.Q. Wang, and G. Romeo. 2003. Mice deficient in the X-linked lymphoproliferative disease gene sap exhibit increased susceptibility to murine gammaherpesvirus-68 and hypo-gammaglobulinemia. J. Med. Virol. 71:446-455.
76. Moorman, N.J., D.O. Willer, and S.H. Speck. 2003. The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J. Virol. 77:10295-10303.
77. Adler, H., M. Messerle, M. Wagner, and U.H. Koszinowski. 2000. Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J. Virol. 74:6964-6974.
78. Weck, K.E., M.L. Barkon, L.I. Yoo, S.H. Speck, and H.I. Virgin. 1996. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J. Virol. 70:6775-6780.